Vonoprazan Versus Lansoprazole in the Healing and Maintenance Phase of Erosive Esophagitis: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
GastroenterologiaSobre o estudo
- Desenho
- Revisão sistemática
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Digestive diseases and sciences
- Publicado em
- 31 jul 2025
- Citações
- 5
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Vonoprazan Versus Lansoprazole in the Healing and Maintenance Phase of Erosive Esophagitis: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
Syed Hasham Ali, Sushil Rayamajhi, Hareesha Rishab Bharadwaj, Aditya Gaur, Muhtasim Fuad, Arkadeep Dhali, Dushyant Singh Dahiya, Matan Bone, Babu Mohan, Sushovan Guha
Descritores MeSH
- Lansoprazole
- Esophagitis, Peptic
- Sulfonamides
- Proton Pump Inhibitors
- Esophagitis
- Pyrroles
- Humans
- Randomized Controlled Trials as Topic
- Treatment Outcome
Veja também
Estudos relacionados
- Network Meta-Analysis of Comparing Different Dosages of Potassium-Competitive Acid Blocker With Proton-Pump Inhibitor in Acid-Related Disorders
- Vonoprazan is superior to lansoprazole for healing of severe but not mild erosive esophagitis: A systematic review with meta-analysis of randomized controlled trials
- Evaluating the cost-effectiveness of replacing lansoprazole with vonoprazan for treating erosive oesophagitis
- Vonoprazan 10 mg or 20 mg vs. lansoprazole 15 mg as maintenance therapy in Asian patients with healed erosive esophagitis: A randomized controlled trial